Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment

Experimental Eye Research

Volumn 101, Issue , 2012, Pages 9-15

  Nolan, John M ^a,b   Akkali, Mukunda C ^a   Loughman, James ^c,d   Howard, Alan N ^e,f   Beatty, Stephen ^a,b  

^a Ireland   (Ireland)

^b Institute of Vision Research   (Ireland)

^c DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^d University of KwaZulu Natal Faculty of Health Sciences   (South Africa)

^e DOWNING COLLEGE   (United Kingdom)

^f Howard Foundation   (United Kingdom)

Author keywords

Age related macular degeneration; Lutein; Macular pigment; Meso zeaxanthin; Zeaxanthin

Indexed keywords

CAROTENOID; MESO ZEAXANTHIN; UNCLASSIFIED DRUG; VISUAL PIGMENT; XANTHOPHYLL; ZEAXANTHIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; DRUG CAPSULE; EYE PROTECTION; FEMALE; HUMAN; MALE; NORMAL HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINA MACULA LUTEA; TREATMENT DURATION; VISION; VITAMIN SUPPLEMENTATION;

ADULT; CAPSULES; DENSITOMETRY; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LUTEIN; MALE; MIDDLE AGED; PHOTOMETRY; QUESTIONNAIRES; RETINA; RETINAL PIGMENTS; VISUAL ACUITY; XANTHOPHYLLS;

EID: 84864295641     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2012.05.006     Document Type: Article

References (41)

1. Bartlett H.E., Eperjesi F. A randomised controlled trial investigating the effect of lutein and antioxidant dietary supplementation on visual function in healthy eyes. Clin. Nutr. 2008, 27:218-227.
2. Berendschot T.T.J.M., van Norren D. Macular pigment shows ringlike structures. Invest. Ophthalmol. Vis. Sci. 2006, 47:709-714.
3. Bhosale P., Bernstein P.S. Synergistic effects of zeaxanthin and its binding protein in the prevention of lipid membrane oxidation. Biochim. Biophys. Acta 2005, 1740:116-121.
4. Bone R.A., Landrum J.T., Fernandez L., Tarsis S.L. Analysis of the macular pigment by HPLC - retinal distribution and age study. Invest. Ophthalmol. Vis. Sci. 1988, 29:843-849.
5. Bone R.A., Landrum J.T., Hime G.W., Cains A., Zamor J. Stereochemistry of the human macular carotenoids. Invest. Ophthalmol. Vis. Sci. 1993, 34:2033-2040.
6. Bone R.A., Landrum J.T., Friedes L.M., Gomez C.M., Kilburn M.D., Menendez E., Vidal I., Wang W.L. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp. Eye Res. 1997, 64:211-218.
7. Cantrell A., McGarvey D.J., Truscott T.G., Rancan F., Bohm F. Singlet oxygen quenching by dietary carotenoids in a model membrane environment. Arch. Biochem. Biophys. 2003, 412:47-54.
8. Connolly E.E., Beatty S., Thurnham D.I., Loughman J., Howard A.N., Stack J., Nolan J.M. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study. Curr. Eye Res. 2010, 35:335-351.
9. Delori F.C., Goger D.G., Keilhauer C., Salvetti P., Staurenghi G. Bimodal spatial distribution of macular pigment: evidence of a gender relationship. J. Opt. Soc. Am. A Opt. Image Sci. Vis 2006, 23:521-538.
10. Dietzel M., Zeimer M., Heimes B., Pauleikhoff D., Hense H.W. The ringlike structure of macular pigment in age-related maculopathy: results from the Muenster Aging and Retina Study (MARS). Invest. Ophthalmol. Vis. Sci. 2011, 52:8016-8024.
11. Engles M., Wooten B., Hammond B. Macular pigment: a test of the acuity hypothesis. Invest. Ophthalmol. Vis. Sci. 2007, 48:2922-2931.
12. Foote C.S., Chang Y.C., Denny R.W. Chemistry of singlet oxygen. X. Carotenoid quenching parallels biological protection. J. Am. Chem. Soc. 1970, 92:5216-5218.
13. Hammond B.R., Wooten B.R., Snodderly D.M. Individual variations in the spatial profile of human macular pigment. J. Opt. Soc. America A-Optics Image Sci. Vis. 1997, 14:1187-1196.
14. Hammond B.R., Wooten B.R. CFF thresholds: relation to macular pigment optical density. Ophthalmic Physiol. Opt. 2005, 25:315-319.
15. Hirsch J., Curcio C.A. The spatial resolution capacity of human foveal retina. Vis. Res. 1989, 29:1095-1101.
16. Johnson E.J., Neuringer M., Russell R.M., Schalch W., Snodderly D.M. Nutritional manipulation of primate retinas, III: effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys. Invest. Ophthalmol. Vis. Sci. 2005, 46:692-702.
17. Khachik F., Bernstein P.S., Garland D.L. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest. Ophthalmol. Vis. Sci. 1997, 38:1802-1811.
18. Kirby M.L., Galea M., Loane E., Stack J., Beatty S., Nolan J.M. Foveal anatomic associations with the secondary peak and the slope of the macular pigment spatial profile. Invest. Ophthalmol. Vis. Sci. 2009, 50:1383-1391.
19. Kirby M.L., Beatty S., Loane E., Akkali M.C., Connolly E.E., Stack J., Nolan J.M. A central dip in the macular pigment spatial profile is associated with age and smoking. Invest. Ophthalmol. Vis. Sci. 2010, 51:6722-6728.
20. Kirschfeld K. Carotenoid pigments: their possible role in protecting against photooxidation in eyes and photoreceptor cells. Proc. R. Soc. Lond B Biol. Sci. 1982, 216:71-85.
21. Klaver C.C.W., Wolfs R.C.W., Vingerling J.R., Hofman A., De Jong P.T.V.M. Age-specific prevalence and causes of blindness and visual impairment in an older population - The Rotterdam Study. Arch. Ophthalmol. 1998, 116:653-658.
22. Kvansakul J., Rodriguez-Carmona M., Edgar D.F., Barker F.M., Kopcke W., Schalch W., Barbur J.L. Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance. Ophthalmic Physiol. Opt. 2006, 26:362-371.
23. Li B., Ahmed F., Bernstein P.S. Studies on the singlet oxygen scavenging mechanism of human macular pigment. Arch. Biochem. Biophys 2010, 504:56-60.
24. Loughman J., Akkali M.C., Beatty S., Scanlon G., Davison P.A., O'Dwyer V., Cantwell T., Major P., Stack J., Nolan J.M. The relationship between macular pigment and visual performance. Vis. Res. 2010, 50:1249-1256.
25. Neuringer M., Sandstrom M.M., Johnson E.J., Snodderly D.M. Nutritional manipulation of primate retinas, I: effects of lutein or zeaxanthin supplements on serum and macular pigment in xanthophyll-free rhesus monkeys. Invest. Ophthalmol. Vis. Sci. 2004, 45:3234-3243.
26. Nolan J.M., O'Reilly P., Loughman J., Stack J., Loane E., Connolly E., Beatty S. Augmentation of macular pigment following implantation of blue light-filtering intraocular lenses at the time of cataract surgery. Invest. Ophthalmol. Vis. Sci. 2009, 50:4777-4785.
27. Nolan J.M., Loughman J., Akkali M.C., Stack J., Scanlon G., Davison P., Beatty S. The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS. Vis. Res. 2011, 51:459-469.
28. Rodriguez-Carmona M., Kvansakul J., Harlow J.A., Kopcke W., Schalch W., Barbur J.L. The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision. Ophthalmic Physiol. Opt. 2006, 26:137-147.
29. Snodderly D.M., Auran J.D., Delori F.C. The macular pigment. II. Spatial distribution in primate retinas. Invest. Ophthalmol. Vis. Sci. 1984, 25:674-685.
30. Snodderly D.M., Brown P.K., Delori F.C., Auran J.D. The macular pigment .1. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest. Ophthalmol. Vis. Sci. 1984, 25:660-673.
31. Snodderly D.M., Handelman G.J., Adler A.J. Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest. Ophthalmol. Vis. Sci. 1991, 32:268-279.
32. Stringham J.M., Hammond B.R. The glare hypothesis of macular pigment function. Optom. Vis. Sci. 2007, 84:859-864.
33. Stringham J.M., Hammond B.R. Macular pigment and visual performance under glare conditions. Optom. Vis. Sci. 2008, 85:82-88.
34. Stringham J.M., Fuld K., Wenzel A.J. Spatial properties of photophobia. Invest. Ophthalmol. Vis. Sci. 2004, 45:3838-3848.
35. Sujak A., Gabrielska J., Grudzinski W., Borc R., Mazurek P., Gruszecki W.I. Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: the structural aspects. Arch. Biochem. Biophys. 1999, 371:301-307.
36. Trieschmann M., Spital G., Lommatzsch A., van Kuijk F.J.G.M., Fitzke F., Bird A., Pauleikhoff D. Macular pigment: quantitative analysis on autofluorescence images. Graefes Arch. Clin. Exp. Ophthalmol. 2003, 241:1006-1012.
37. Trieschmann M., Beatty S., Nolan J.M., Hense H.W., Heimes B., Austermann U., Fobker M., Pauleikhoff D. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp. Eye Res. 2007, 84:718-728.
38. Trieschmann M., van Kuijk F.J., Alexander R., Hermans P., Luthert P., Bird A.C., Pauleikhoff D. Macular pigment in the human retina: histological evaluation of localization and distribution. Eye 2008, 22:132-137.
39. Wooten B.R., Hammond B.R. Macular pigment: influences on visual acuity and visibility. Prog. Retin. Eye Res. 2002, 21:225-240.
40. Wooten B.R., Hammond B.R. Spectral absorbance and spatial distribution of macular pigment using heterochromatic flicker photometry. Optom. Vis. Sci. 2005, 82:378-386.
41. Wrona M., Rozanowska M., Sarna T. Zeaxanthin in combination with ascorbic acid or alpha-tocopherol protects ARPE-19 cells against photosensitized peroxidation of lipids. Free Radic. Biol. Med 2004, 36:1094-1101.